Neurobo Pharmaceuticals, INC. (MTVA) — SC 13D/A Filings
All SC 13D/A filings from Neurobo Pharmaceuticals, INC.. Browse 2 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (2)
-
Dong-A ST Amends NeuroBo Pharmaceuticals Stake
— Sep 20, 2024 Risk: medium
Dong-A ST Co., Ltd. filed an amendment (Amendment #7) to its Schedule 13D on September 20, 2024, regarding its holdings in NeuroBo Pharmaceuticals, Inc. The fil -
Dong-A ST Files 13D/A for NeuroBo Pharmaceuticals
— Jun 25, 2024 Risk: medium
Dong-A ST Co., Ltd. has filed an amendment (Amendment #6) to its Schedule 13D for NeuroBo Pharmaceuticals, Inc. on June 25, 2024. This filing relates to the com
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX